1. Home
  2. IRD vs SHOT Comparison

IRD vs SHOT Comparison

Compare IRD & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • SHOT
  • Stock Information
  • Founded
  • IRD 2018
  • SHOT 2018
  • Country
  • IRD United States
  • SHOT United States
  • Employees
  • IRD N/A
  • SHOT N/A
  • Industry
  • IRD
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRD
  • SHOT Health Care
  • Exchange
  • IRD NYSE
  • SHOT Nasdaq
  • Market Cap
  • IRD 36.1M
  • SHOT 31.4M
  • IPO Year
  • IRD N/A
  • SHOT 2020
  • Fundamental
  • Price
  • IRD $1.15
  • SHOT $0.53
  • Analyst Decision
  • IRD Strong Buy
  • SHOT
  • Analyst Count
  • IRD 1
  • SHOT 0
  • Target Price
  • IRD $8.00
  • SHOT N/A
  • AVG Volume (30 Days)
  • IRD 153.1K
  • SHOT 933.2K
  • Earning Date
  • IRD 02-19-2025
  • SHOT 03-31-2025
  • Dividend Yield
  • IRD N/A
  • SHOT N/A
  • EPS Growth
  • IRD N/A
  • SHOT N/A
  • EPS
  • IRD N/A
  • SHOT N/A
  • Revenue
  • IRD $8,381,000.00
  • SHOT $652,495.00
  • Revenue This Year
  • IRD N/A
  • SHOT N/A
  • Revenue Next Year
  • IRD $29.37
  • SHOT N/A
  • P/E Ratio
  • IRD N/A
  • SHOT N/A
  • Revenue Growth
  • IRD N/A
  • SHOT 68.01
  • 52 Week Low
  • IRD $0.81
  • SHOT $0.45
  • 52 Week High
  • IRD $2.77
  • SHOT $3.95
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • SHOT 43.17
  • Support Level
  • IRD N/A
  • SHOT $0.45
  • Resistance Level
  • IRD N/A
  • SHOT $0.52
  • Average True Range (ATR)
  • IRD 0.00
  • SHOT 0.05
  • MACD
  • IRD 0.00
  • SHOT 0.01
  • Stochastic Oscillator
  • IRD 0.00
  • SHOT 59.06

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: